Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
02/06/202420:45PR Newswire (US)izmostock Unveils Revolutionary Image Solution for Leasing Industry, Driving Unparalleled ROI and User Engagement
02/06/202419:53PR Newswire (US)GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
02/06/202417:40PR Newswire (US)GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
02/06/202417:30PR Newswire (US)Miami Beach Inspires this Summer with Film, Fashion and Music Experiences
02/06/202416:32PR Newswire (US)Rokid AR Lite Crowdfunding Surpasses $600,000 with One Day Left for Early Bird Price of $479
02/06/202416:24PR Newswire (US)Discovery of World War II fighter plane sets path for first U.S.-Papua New Guinea Sister City
02/06/202416:13PR Newswire (US)LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
02/06/202416:00PR Newswire (US)WafaTech Unveils Comprehensive Suite of Cloud, Connectivity, and ICT Solutions for Saudi Arabia
02/06/202416:00PR Newswire (US)Linker Vision to Accelerate Vision AI Adoption Across Enterprise Applications with Large Vision Models, in Collaboration with NVIDIA
02/06/202415:45PR Newswire (US)ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA
02/06/202415:25PR Newswire (US)ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024
02/06/202415:00PR Newswire (US)MEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer
02/06/202415:00PR Newswire (US)Flamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC)
02/06/202414:47PR Newswire (US)Federal Government Authorizes Institute of Information Management to Certify Data Protection Professionals in Nigeria
02/06/202414:43PR Newswire (US)Federal Government Authorizes Institute of Information Management to Certify Data Protection Professionals in Nigeria
02/06/202414:30PR Newswire (US)Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care
02/06/202413:42PR Newswire (US)Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
02/06/202413:30PR Newswire (US)Vention to democratize industrial automation using NVIDIA AI technologies
02/06/202413:30PR Newswire (US)Crimson Cup Coffee & Tea Publishes 2024 Guide on How to Start a Coffee Shop in California
02/06/202413:00PR Newswire (US)OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
02/06/202412:00PR Newswire (US)Fast Guard Service Releases Guide to Choosing the Best Fire Watch Service
02/06/202411:41Alliance NewsAlliance NewsIsrael fights Hamas as mediators urge both to accept Gaza truce plan
02/06/202411:35Alliance NewsAlliance NewsOPEC+ anxious to maintain unity as some members head to Riyadh
02/06/202411:32Alliance NewsAlliance NewsDong Jun says Beijing ready to "forcefully" stop Taiwan independence
02/06/202411:29Alliance NewsAlliance NewsNvidia head, top chip CEOs to lay out AI plans at Taiwan expoTG:NVDNVIDIA Corp
02/06/202411:20Alliance NewsAlliance NewsPRESS: Sanofi proceeds with EUR20 billion consumer healthcare spin-off
02/06/202411:18PR Newswire (US)Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
02/06/202404:56PR Newswire (US)Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC
02/06/202401:25PR Newswire (US)Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
02/06/202401:17PR Newswire (US)CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC

Your Recent History

Delayed Upgrade Clock